AMGEN INC

Amgen Inc. in Singapore is primarily a factory (manufacturing site) with significant commercial operations.

Company Introduction for Amgen Inc., Singapore

Nature of Business: Amgen Inc. in Singapore operates primarily as a manufacturing facility (factory) for biopharmaceuticals, alongside its commercial and regional functions. It is a key part of Amgen's global supply chain and research and development network.

Overview:

Amgen is one of the world's leading independent biotechnology companies, dedicated to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics.

In Singapore, Amgen has established a state-of-the-art biomanufacturing facility. This facility is highly advanced and incorporates innovative manufacturing technologies, demonstrating Amgen's commitment to efficiency and sustainability in biopharmaceutical production. Beyond manufacturing, Amgen Singapore also serves as a commercial hub, managing sales, marketing, and distribution of its innovative medicines across the region. The company is involved in various activities including research and development support, clinical trials, and strategic partnerships, contributing to Singapore's vibrant biomedical sciences ecosystem.

Amgen Inc. in Singapore produces or sells the following products:

Repatha (evolocumab)

Prolia (denosumab)

Xgeva (denosumab)

Evenity (romosozumab)

Neulasta (pegfilgrastim)

Nplate (romiplostim)

Kyprolis (carfilzomib)

Blincyto (blinatumomab)

Vectibix (panitumumab)

Otezla (apremilast)

Parsabiv (etelcalcetide)

Aimovig (erenumab)